Asia-Pacific Remicade Biosimilar Market Report 2017

January 2018 | 107 pages | ID: A5BE8A7440EEN
QYResearch

Abstracts

In this report, the Asia-Pacific Remicade Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Remicade Biosimilar for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Remicade Biosimilar market competition by top manufacturers/players, with Remicade Biosimilar sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva Pharmaceutical Industries
• Synthon Pharmaceuticals
• LG Life Sciences
• Novartis (Sandoz)
• Celltrion
• Biocon
• Hospira
• Merck Serono (Merck Group)
• Biogen idec Inc.
• Genentech (Roche Group)

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• 100mg/10ml
• 500mg/50ml

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Blood Disorders
• Oncology Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Remicade Biosimilar Market Report 2017

1 REMICADE BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Classification of Remicade Biosimilar by Product Category
  1.2.1 Asia-Pacific Remicade Biosimilar Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Remicade Biosimilar Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 100mg/10ml
  1.2.4 500mg/50ml
1.3 Asia-Pacific Remicade Biosimilar Market by Application/End Users
  1.3.1 Asia-Pacific Remicade Biosimilar Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Blood Disorders
  1.3.3 Oncology Diseases
1.4 Asia-Pacific Remicade Biosimilar Market by Region
  1.4.1 Asia-Pacific Remicade Biosimilar Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Remicade Biosimilar (2012-2022)
  1.5.1 Asia-Pacific Remicade Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Remicade Biosimilar Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC REMICADE BIOSIMILAR COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Remicade Biosimilar Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Remicade Biosimilar Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Remicade Biosimilar Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Remicade Biosimilar (Volume and Value) by Type
  2.2.1 Asia-Pacific Remicade Biosimilar Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Remicade Biosimilar Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Remicade Biosimilar (Volume) by Application
2.4 Asia-Pacific Remicade Biosimilar (Volume and Value) by Region
  2.4.1 Asia-Pacific Remicade Biosimilar Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Remicade Biosimilar Revenue and Market Share by Region (2012-2017)

3 CHINA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 China Remicade Biosimilar Sales and Value (2012-2017)
  3.1.1 China Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  3.1.3 China Remicade Biosimilar Sales Price Trend (2012-2017)
3.2 China Remicade Biosimilar Sales Volume and Market Share by Type
3.3 China Remicade Biosimilar Sales Volume and Market Share by Application

4 JAPAN REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Remicade Biosimilar Sales and Value (2012-2017)
  4.1.1 Japan Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Remicade Biosimilar Sales Price Trend (2012-2017)
4.2 Japan Remicade Biosimilar Sales Volume and Market Share by Type
4.3 Japan Remicade Biosimilar Sales Volume and Market Share by Application

5 SOUTH KOREA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Remicade Biosimilar Sales and Value (2012-2017)
  5.1.1 South Korea Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Remicade Biosimilar Sales Price Trend (2012-2017)
5.2 South Korea Remicade Biosimilar Sales Volume and Market Share by Type
5.3 South Korea Remicade Biosimilar Sales Volume and Market Share by Application

6 TAIWAN REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Remicade Biosimilar Sales and Value (2012-2017)
  6.1.1 Taiwan Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Remicade Biosimilar Sales Price Trend (2012-2017)
6.2 Taiwan Remicade Biosimilar Sales Volume and Market Share by Type
6.3 Taiwan Remicade Biosimilar Sales Volume and Market Share by Application

7 INDIA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 India Remicade Biosimilar Sales and Value (2012-2017)
  7.1.1 India Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  7.1.3 India Remicade Biosimilar Sales Price Trend (2012-2017)
7.2 India Remicade Biosimilar Sales Volume and Market Share by Type
7.3 India Remicade Biosimilar Sales Volume and Market Share by Application

8 SOUTHEAST ASIA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Remicade Biosimilar Sales and Value (2012-2017)
  8.1.1 Southeast Asia Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Remicade Biosimilar Sales Price Trend (2012-2017)
8.2 Southeast Asia Remicade Biosimilar Sales Volume and Market Share by Type
8.3 Southeast Asia Remicade Biosimilar Sales Volume and Market Share by Application

9 AUSTRALIA REMICADE BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Remicade Biosimilar Sales and Value (2012-2017)
  9.1.1 Australia Remicade Biosimilar Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Remicade Biosimilar Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Remicade Biosimilar Sales Price Trend (2012-2017)
9.2 Australia Remicade Biosimilar Sales Volume and Market Share by Type
9.3 Australia Remicade Biosimilar Sales Volume and Market Share by Application

10 ASIA-PACIFIC REMICADE BIOSIMILAR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Teva Pharmaceutical Industries
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Remicade Biosimilar Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Synthon Pharmaceuticals
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Remicade Biosimilar Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 LG Life Sciences
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Remicade Biosimilar Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Novartis (Sandoz)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Remicade Biosimilar Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Celltrion
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Remicade Biosimilar Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Biocon
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Remicade Biosimilar Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Hospira
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Remicade Biosimilar Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Merck Serono (Merck Group)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Remicade Biosimilar Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Biogen idec Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Remicade Biosimilar Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Genentech (Roche Group)
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Remicade Biosimilar Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 REMICADE BIOSIMILAR MANUFACTURING COST ANALYSIS

11.1 Remicade Biosimilar Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Remicade Biosimilar

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Remicade Biosimilar Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC REMICADE BIOSIMILAR MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Remicade Biosimilar Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Remicade Biosimilar Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Remicade Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Remicade Biosimilar Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Remicade Biosimilar Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Remicade Biosimilar Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Remicade Biosimilar Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Remicade Biosimilar Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Remicade Biosimilar Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Remicade Biosimilar Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Remicade Biosimilar Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Remicade Biosimilar Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Remicade Biosimilar Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Remicade Biosimilar
Figure Asia-Pacific Remicade Biosimilar Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Remicade Biosimilar Sales Volume Market Share by Type (Product Category) in 2016
Figure 100mg/10ml Product Picture
Figure 500mg/50ml Product Picture
Figure Asia-Pacific Remicade Biosimilar Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Remicade Biosimilar by Application in 2016
Figure Blood Disorders Examples
Table Key Downstream Customer in Blood Disorders
Figure Oncology Diseases Examples
Table Key Downstream Customer in Oncology Diseases
Figure Asia-Pacific Remicade Biosimilar Market Size (Million USD) by Region (2012-2022)
Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Remicade Biosimilar Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Remicade Biosimilar Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Remicade Biosimilar Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Remicade Biosimilar Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Remicade Biosimilar Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Remicade Biosimilar Sales Share by Players/Suppliers
Figure Asia-Pacific Remicade Biosimilar Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Remicade Biosimilar Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Remicade Biosimilar Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Remicade Biosimilar Revenue Share by Players
Figure 2017 Asia-Pacific Remicade Biosimilar Revenue Share by Players
Table Asia-Pacific Remicade Biosimilar Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Remicade Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Remicade Biosimilar by Type (2012-2017)
Figure Asia-Pacific Remicade Biosimilar Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Remicade Biosimilar Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Remicade Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Remicade Biosimilar by Type (2012-2017)
Figure Asia-Pacific Remicade Biosimilar Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Remicade Biosimilar Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Remicade Biosimilar Sales Share by Region (2012-2017)
Figure Sales Market Share of Remicade Biosimilar by Region (2012-2017)
Figure Asia-Pacific Remicade Biosimilar Sales Market Share by Region in 2016
Table Asia-Pacific Remicade Biosimilar Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Remicade Biosimilar Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Remicade Biosimilar by Region (2012-2017)
Figure Asia-Pacific Remicade Biosimilar Revenue Market Share by Region in 2016
Table Asia-Pacific Remicade Biosimilar Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Remicade Biosimilar Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Remicade Biosimilar Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Remicade Biosimilar Sales Market Share by Application (2012-2017)
Figure China Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table China Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table China Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure China Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table China Remicade Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table China Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure China Remicade Biosimilar Sales Volume Market Share by Application in 2016
Figure Japan Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Japan Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Japan Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table Japan Remicade Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Japan Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Japan Remicade Biosimilar Sales Volume Market Share by Application in 2016
Figure South Korea Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table South Korea Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure South Korea Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table South Korea Remicade Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure South Korea Remicade Biosimilar Sales Volume Market Share by Application in 2016
Figure Taiwan Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table Taiwan Remicade Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Remicade Biosimilar Sales Volume Market Share by Application in 2016
Figure India Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure India Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table India Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table India Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure India Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table India Remicade Biosimilar Sales Volume (K Units) by Application (2012-2017)
Table India Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure India Remicade Biosimilar Sales Volume Market Share by Application in 2016
Figure Southeast Asia Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table Southeast Asia Remicade Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Remicade Biosimilar Sales Volume Market Share by Application in 2016
Figure Australia Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Remicade Biosimilar Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Remicade Biosimilar Sales Volume (K Units) by Type (2012-2017)
Table Australia Remicade Biosimilar Sales Volume Market Share by Type (2012-2017)
Figure Australia Remicade Biosimilar Sales Volume Market Share by Type in 2016
Table Australia Remicade Biosimilar Sales Volume (K Units) by Applications (2012-2017)
Table Australia Remicade Biosimilar Sales Volume Market Share by Application (2012-2017)
Figure Australia Remicade Biosimilar Sales Volume Market Share by Application in 2016
Table Teva Pharmaceutical Industries Remicade Biosimilar Basic Information List
Table Teva Pharmaceutical Industries Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Synthon Pharmaceuticals Remicade Biosimilar Basic Information List
Table Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table LG Life Sciences Remicade Biosimilar Basic Information List
Table LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis (Sandoz) Remicade Biosimilar Basic Information List
Table Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Celltrion Remicade Biosimilar Basic Information List
Table Celltrion Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Celltrion Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Celltrion Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Biocon Remicade Biosimilar Basic Information List
Table Biocon Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Biocon Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Biocon Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Hospira Remicade Biosimilar Basic Information List
Table Hospira Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Hospira Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Hospira Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck Serono (Merck Group) Remicade Biosimilar Basic Information List
Table Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Biogen idec Inc. Remicade Biosimilar Basic Information List
Table Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Genentech (Roche Group) Remicade Biosimilar Basic Information List
Table Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Sales (K Units) and Growth Rate (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Sales Market Share in Asia-Pacific (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Remicade Biosimilar
Figure Manufacturing Process Analysis of Remicade Biosimilar
Figure Remicade Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2016
Table Major Buyers of Remicade Biosimilar
Table Distributors/Traders List
Figure Asia-Pacific Remicade Biosimilar Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Remicade Biosimilar Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Remicade Biosimilar Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Revenue Market Share Forecast by Region in 2022
Figure China Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Remicade Biosimilar Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Remicade Biosimilar Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Remicade Biosimilar Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Remicade Biosimilar Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Remicade Biosimilar Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Remicade Biosimilar Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources